Patrocinado
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Postado
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Pesquisar
Categorias
- National
- International
- Business
- Technology
- Health
- Educação
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leia Mais
Today’s News in a Nutshell
KATHMANDU: Khabarhub brings you a glimpse of major developments of the day in Nepal, including...
Donald Trump fires new tariff salvo! Letters to more countries released; Iraq, Philippines & others to face up to 30% duties - check list
Donald Trump issued tariff letters to several countries, including the Philippines, Brunei,...
Diljit hints at still being a part of No Entry 2 from Border 2 set
Diljit Dosanjh's involvement in 'Border 2' and a video featuring Anees Bazmee have stirred...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Portuguese
